Detection and quantification of cardiovascular calcifications with electron beam tomography to estimate risk in hemodialysis patients

Clinical Nephrology

Volumn 54, Issue 4, 2000, Pages 325-333

  Raggi, P ^a  

^a NONE   (United States)

Author keywords

Calcification; Calcium; Cardiovascular disease; Chronic renal failure; Coronary artery disease; EBCT; Hemodialysis; Phosphate binders; Phosphorus

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; PHOSPHATE BINDING AGENT; PHOSPHORUS; VITAMIN D DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD VESSEL CALCIFICATION; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; CORONARY ARTERY ATHEROSCLEROSIS; DIALYSATE; DISEASE COURSE; ELECTRON BEAM TOMOGRAPHY; FEMALE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; MALE; PHOSPHATE BLOOD LEVEL; RISK ASSESSMENT; SOFT TISSUE CALCIFICATION; VALVULAR HEART DISEASE;

CALCINOSIS; CARDIOVASCULAR SYSTEM; HUMAN; SUPPORT, NON-U.S. GOV'T; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033774502     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Quantification of coronary artery calcium using ultrafast computed tomography
2. Predictive value of electron beam computed tomography of the coronary arteries. 19-Month follow-up of 1173 asymptomatic subjects
3. Comparison of electron beam computed tomography with intracoronary ultrasound and coronary angiography for detection of coronary atherosclerosis
4. A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients
5. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
6. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management
7. Arteriosclerosis in dialysis patients
8. Bone morphogenetic protein expression in human atherosclerotic lesions
9. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients
10. Coronary artery calcification detected with ultrafast CT as an indication of coronary artery disease
11. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: A multicenter study
12. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography
13. Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients
14. A clinical approach to the uraemic patient with extraskeletal calcifications
15. Clinical epidemiology of cardiovascular disease in chronic renal disease
16. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
17. Arterial stiffening and vascular calcifications in end-stage renal disease
18. Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia
19. Are we mismanaging calcium and phosphate metabolism in renal failure?
20. Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women
21. Factors associated with calcification of the abdominal aorta in hemodialysis patients
22. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease
23. Calcific aortic stenosis: A complication of chronic uraemia
24. Aortic and mitral valve calcification in patients with end-stage renal disease
25. Progression of coronary artery calcification: A pilot study
26. Hypertension in the ESRD patient: Pathophysiology, therapy, outcomes, and future directions
27. Dialysis: Current status, contemporary limitations and future challenges
28. Role of ageing, chronic renal failure and dialysis in the calcification of mitral annulus
29. Soft tissue calcification in pediatric patients with end-stage renal disease
30. Characterization of myocardial tissue in patients undergoing maintenance hemodialysis by quantitative echocardiography
31. Toward a new treatment paradigm for hyperphosphatemia in chronic renal disease
32. Hyperlipidemia in pediatric hemodialysis and renal transplant patients. Associated with coronary artery disease
33. Regression of calcified coronary artery plaque assessed by electron beam computed tomography
34. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography
35. Cardiac calcification is prevalent and severe in a group of 203 ESRD patients as measured by electron beam CT scanning
36. Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism
37. Myocardial calcification and cardiac dysfunction in chronic renal failure
38. Coronary calcification by electron beam computed tomography and obstructive coronary artery disease: A model for costs and effectiveness of diagnosis as compared with conventional cardiac testing methods
39. Electron beam computed tomographic coronary calcium scanning: A review and guidelines for use in asymptomatic persons
40. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: A histologic study of 723 coronary artery segments using nondecalcifying methodology
41. Coronary artery calcium in acute coronary syndromes: A comparative study of electron-beam computed tomography, coronary angiography, and intracoronary ultrasound in survivors of acute myocardial infarction and unstable angina
42. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure
43. 3): An efficient and safe phosphate binder in haemodialysis patients? A 3-year study
44. Coronary artery calcification: Pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group
45. Simultaneous lowering of serum phosphate and LDL-cholesterol by sevelamer hydrochloride (RenaGel) in dialysis patients
46. Calcium use increases risk of calciphylaxis: A case-control study